These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4339821)

  • 1. Evaluation of sickle hemoglobin and desickling agents by falling ball viscometry.
    Paniker NV; Ben-Bassat I; Beutler E
    J Lab Clin Med; 1972 Aug; 80(2):282-90. PubMed ID: 4339821
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in vitro.
    Kraus LM; Kraus AP
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1381-7. PubMed ID: 4946263
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 4. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridoxine administration in sickle cell disease: an unsuccessful attempt to influence the properties of sickle hemoglobin.
    Beutler E; Paniker NV; West CJ
    Biochem Med; 1972 Apr; 6(2):139-43. PubMed ID: 5027148
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and physiological properties of carbamylated hemoglobin S.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Enzymol Relat Areas Mol Biol; 1974; 40(0):1-27. PubMed ID: 4600763
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pH, 2,3-diphosphoglycerate and salts on gelation of sickle cell deoxyhemoglobin.
    Briehl RW; Ewert S
    J Mol Biol; 1973 Nov; 80(3):445-58. PubMed ID: 4762563
    [No Abstract]   [Full Text] [Related]  

  • 11. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs in the treatment of sickle cell anemia.
    Freedman ML
    Am J Med Sci; 1973 May; 265(5):371-3. PubMed ID: 4576757
    [No Abstract]   [Full Text] [Related]  

  • 15. Viscosity and gelation studies in deer hunting hemoglobins.
    Wong SC; Huisman TH
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):581-4. PubMed ID: 1208578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of cyanate with a summary of its initial usage in sickle cell disease.
    Gillette PN; Lu YS; Peterson CM
    Prog Hematol; 1973; 8():181-90. PubMed ID: 4788375
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of the carbamylation of the amino groups of sickle cell hemoglobin by cyanate.
    Lee CK; Manning JM
    J Biol Chem; 1973 Aug; 248(16):5861-5. PubMed ID: 4723918
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of intracellular hemoglobin with pyridoxal and pyridoxal 5'-phosphate.
    Kark JA; Bongiovanni R; Hicks CU; Tarassoff PG; Hannah JS; Yoshida GY
    Blood Cells; 1982; 8(2):299-314. PubMed ID: 7159754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial blood pressure and hyperviscosity in sickle cell disease.
    Johnson CS
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):827-37, vi. PubMed ID: 16214646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of several methods used in the detection of sickle cell disease.
    Schorr KA; Tischer RG
    Am J Med Technol; 1973 Mar; 39(3):102-6. PubMed ID: 4701363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.